Abnormal IGF1R and VEGF-C expressions, therefore, might constitute important markers for lymph node metastasis of endometrial adenocarcinoma and might be potentially useful for evaluating disease prognosis. This evidence concerns the gene IGF1R and endometrium adenocarcinoma.